Prehabilitation Program for High-Risk Hematopoietic Stem Cell Transplant Patients

This study is testing an 8-week at-home, personalized exercise program called a "Cardio-oncology program" for people who are at high risk for heart problems and are going to have a hematopoietic stem cell transplant (HSCT). The program aims to improve your heart and lung fitness and reduce heart-related complications after your transplant. To join, you must be 18 or older, referred for HSCT, have at least one heart risk factor (like high blood pressure or diabetes), and be able to walk without help. Researchers will measure how easy it is to recruit and keep people in the program. The study is currently unclear on its status and plans to enroll 10 participants.

Study design
This is an interventional study with no specified phase, planning to enroll 10 participants.
What's involved
You would have an initial heart evaluation, participate in an 8-week at-home exercise program, and then have another heart evaluation before your transplant.
Compensation
Not stated in the trial record.
Follow-up
The primary goals are measured at 8 weeks post enrollment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05945121

Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation

Recruiting
NAAges 18+InterventionalSupportive care
University of Michigan Rogel Cancer Center
~10 participants
Updated 2026-05-04 on ClinicalTrials.gov
What's tested:Cardio-oncology program

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of a cardio-oncology prehabilitation program in high-risk HSCT candidates (Recruitment Rate).
Measured over 8 weeks post enrollment
+12 more outcomes measured
Hematopoietic Stem Cell Transplant
1 sites across 1 states
Michigan1
  • Salim Hayek · PRINCIPAL_INVESTIGATOR · University of Michigan Rogel Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adult 18 years or older
Referred for HSCT evaluation
Presence of least one CV risk factor at enrollment (hypertension, hyperlipidemia, atrial fibrillation, obesity, heart failure, history of coronary artery disease, diabetes)
Able to ambulate unassisted
Ability to understand and the willingness to sign a written informed consent
Ability to use Polar Flow heart rate application

Exclusion

Severe anemia (hemoglobin \<7 gm/dl)
Untreated high-risk coronary artery disease (left main, triple vessel disease)
Severe aortic stenosis
Recent fracture as assessed via self-report
Gross balance deficits
Severe pain with basic movement
Unable to ambulate unassisted or exercise
NYHA class IV heart failure
Adults unable to give consent, pregnant women, and prisoners are excluded from this study.
  • Feasibility of a cardio-oncology prehabilitation program in high-risk HSCT candidates (Recruitment Rate).8 weeks post enrollment

    Percent of eligible participants who are screened and give informed consent

  • Feasibility of a cardio-oncology prehabilitation program in high-risk HSCT candidates (retention Rates).8 weeks post enrollment

    percentage of enrolled participants who complete pre-post CV assessments

  • Feasibility of a cardio-oncology prehabilitation program in high-risk HSCT candidates (Duration of Recruitment).8 weeks post enrollment

    the number of participants recruited per month

  • Feasibility of a cardio-oncology prehabilitation program in high-risk HSCT candidates (time to implement study protocol).8 weeks post enrollment

    the average amount of time required for participants to complete initial and follow-up CV assessments

  • Feasibility of a cardio-oncology prehabilitation program in high-risk HSCT candidates (adherence to program- Days).8 weeks post enrollment

    The percentage of days of exercised out of 24 days recommended over the 8 weeks for both aerobic and resistance activities.

  • Feasibility of a cardio-oncology prehabilitation program in high-risk HSCT candidates (adherence to program- Time).8 weeks post enrollment

    The average duration (min) of aerobic and resistance workouts over the course of the intervention.

  • Feasibility of a cardio-oncology prehabilitation program in high-risk HSCT candidates (adherence to program- Missing data).8 weeks post enrollment

    the percentage of missing data from study questionnaires.

  • Feasibility of a cardio-oncology prehabilitation program in high-risk HSCT candidates (overall satisfaction).8 weeks post enrollment

    Assessed qualitatively with in-depth, semi-structured, one-to-one exit interviews with participants. A member of the research team experienced with telephone interviews, but not involved in intervention delivery, will contact all patients within 1 week after completion of the final follow-up assessment.The researcher will facilitate the interviews using a conversational-style approach whilst referring to a topic guide. Topics will focus on patients' perceived expectations, benefits, motives, and barriers to the program. The researcher will additionally ask questions regarding reasons for non-adherence to the exercise intervention, and reasons for dropout amongst discontinuing patients. The topic guide will be used flexibly to allow patients to raise additional issues which they consider important to the study. Interviews will be recorded with participants knowledge and then transcribed, coded, and assessed for relevant themes and recommendations using iterative thematic analysis

  • Preliminary effectiveness of an 8-week cardio-oncology prehabilitation on measures of CRF in high-risk HSCT candidates (change in anaerobic threshold).8 weeks post enrollment

    change in anaerobic threshold from pre to post intervention reported in L/min

  • Preliminary effectiveness of an 8-week cardio-oncology prehabilitation on measures of CRF in high-risk HSCT candidates (change in VO2peak).8 weeks post enrollment

    change in VO2peak from pre to post intervention reported in ml/kg/min

  • Preliminary effectiveness of an 8-week cardio-oncology prehabilitation on measures of CRF in high-risk HSCT candidates (comparison of V02 peak to predicted).8 weeks post enrollment

    Comparison of V02 peak assessed after intervention in comparison to the predicted values reported as the percent difference between the values

  • Preliminary effectiveness of an 8-week cardio-oncology prehabilitation on measures of CRF in high-risk HSCT candidates (RER).8 weeks post enrollment

    change in RER (a ratio between cardiac dioxide output (VCO2)/oxygen uptake (VO2)) from pre to post intervention reported as the percent difference between the values

  • Preliminary effectiveness of an 8-week cardio-oncology prehabilitation on measures of CRF in high-risk HSCT candidates (VE/VC02 slope).8 weeks post enrollment

    Change in VE/VC02 slope (defined as the change in minute ventilation per unit of carbon dioxide production) from pre to post intervention